Why the study?
Information on the clinical profile of patients with heart failure from the Nepalese population was limited.
In a Nepalese hospital cohort, heart failure is predominantly caused by ischemic and rheumatic heart disease, with a high prevalence of anemia and significant underutilization of guideline-directed medical therapies like beta-blockers and ACE inhibitors.
Answers are grounded in this paper and cite their sources.
Provides baseline HF profile in Nepalese patients; leaves open need for prospective studies before informing local practice.
Background: There is limited information on the clinical profile of patients with heart failure from the Nepalese population. Materials and Methods: This is a descriptive cross-sectional study on 120 consecutive patients with New York Heart Association class II or IV symptoms of heart failure admitted from June 2018 to January 2019 at Nobel Medical College Teaching hospital, Biratnagar, Nepal. Results: Mean age was 52.2 ± 20.6 years. The male and female ratio was 0.71. Ischemic cardiomyopathy, rheumatic heart disease, dilated cardiomyopathy, acute coronary syndrome, hypertensive heart disease, and peripartum cardiomyopathy were common etiologies constituting 22.5%, 19.1%,13.3%, 9.1%, 8.3 %, 5% of cases respectively. Among co-morbid conditions, anemia (91.6%),hypertension (31.6%), coronary artery disease (29.1%), diabetes (20.8%) and chronic kidney disease (11.6%) were common. Among various drugs used, 66.6% patients were prescribed diuretics, 60% mineral corticoid receptor blockers, 33.3% angiotensin-converting enzymeinhibitors, 33.3% beta-blockers, 29.1% digoxin and 8.3% angiotensin receptor blockers. Echocardiography revealed LV systolic and diastolic dysfunction in 75% and 25% respectively, mitral regurgitation in 52.5%, right ventricular dysfunction in 10.8 % and pulmonary artery hypertension in 66.6%. Conclusion: Appropriate use of evidence-based therapies, careful attention to the diagnosis and management of specific co-morbidities in patients with HF may help to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Monib et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: